Mechanistic considerations in benzene physiological model development

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 6, 1996, Pages 1399-1404

  Medinsky, Michele A ^a   Kenyon, Elaina M ^a   Seaton, Mark J ^a   Schlosser, Paul M ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

Benzene; Human metabolism; Hydroquinone; Phenol; Physiological modeling

Indexed keywords

BENZENE; BENZOQUINONE; CIGARETTE SMOKE; CYTOCHROME P450; GASOLINE; HYDROQUINONE; MYELOPEROXIDASE; PHENOL; SOLVENT;

ACINAR CELL; ACUTE GRANULOCYTIC LEUKEMIA; APLASTIC ANEMIA; BONE MARROW; CANCER RISK; COMPETITIVE INHIBITION; CONFERENCE PAPER; CONJUGATION; DOSIMETRY; EXCRETION; HUMAN; LIVER; METABOLISM; OXIDATION; PANCYTOPENIA; PRIORITY JOURNAL; TARGET ORGAN;

EID: 0030464772     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.961041399     Document Type: Conference Paper

References (39)

1. Runion, HE, Scott, LM. Benzene exposure in the United States 1978-1983: an overview. Am J Ind Med 7:385-393 (1985).
2. Wallace L. Major sources of exposure to benzene and other volatile organic chemicals. Risk Anal 10:59-64 (1990).
3. Goldstein, BD. Hematotoxicity in humans. J Toxicol Environ Health Suppl 2:69-105 (1977).
4. Rinsky RA, Smith, AB, Hornung R, Filloon TG, Young RJ, Okun AH, Landrigan PJ. Benzene and leukemia, and epidemiological risk assessment. N Engl J Med 316:1044-1050 (1987).
5. Seaton MJ, Medinsky MA. Experimental studies of benzene carcinogenicity. Update on benzene. In: The Books of Medicine and Rehabilitative Medicine (Marcello I, ed), in press.
6. Snyder R, Kalf GF. A perspective on benzene leukemogenesis. Crit Rev Toxicol 24:177-209 (1994).
7. Irons RD, Stillman WS, Colagiovanni DB, Henry VA. Synergistic action of benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating in vitro. Proc Natl Acad Sci USA 89:3691-3695 (1992).
8. Eastmond DA, Smith MT, Irons RD. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene. Toxicol Appl Pharmacol 91: 85-95 (1987).
9. Barale R, Marrazzini A, Betti C, Vangelisti V, Loprieno N, Barrai I. Genotoxicity of two metabolites of benzene: phenol and hydroquinone show strong synergistic effects in vivo. Mutat Res 244:15-20 (1990).
10. Smith MT, Yager JW, Steinmetz KL, Eastmond DA. Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ Health Perspect 82:23-29 (1989).
11. Schlosser PM, Bond JA, Medinsky MA. Benzene and phenol metabolism by mouse and rat liver microsomes. Carcinogenesis 14:2477-2486 (1993).
12. Koop DR, Laethem CL, Schnier GG. Identification of ethanol-inducible P450 isozyme 3a (P450IIE1) as a benzene and phenol hydroxylase. Toxicol Appl Pharmacol 98:278-288 (1989).
13. Seaton MJ, Schlosser PM, Bond JA, Medinsky MA. In vitro conjugation of benzene metabolites by human liver: potential influence of interindividual variability on benzene toxicity. Carcinogenesis 16:1519-1527 (1995).
14. Erexson GL, Wilmer JL, Kligerman AD. Sister chromatid exchange induction in human lymphocytes exposed to benzene and its metabolites in vitro. Cancer Res 45:2471-2477 (1985).
15. Sabourin PJ, Bechtold WE, Griffith WC, Birnbaum LS, Lucier G, Henderson RF. Effect of exposure concentration, exposure rate and route of administration on metabolism of benzene by F344 rats and B6C3F1 mice. Toxicol Appl Pharmacol 99:421-444 (1989).
16. 14C-benzene administered orally or by inhalation in rats and mice. Toxicol Appl Pharmacol 87:325-336 (1987)
17. Medinsky MA, Sabourin PJ, Lucier G, Birnbaum LS, Henderson RF. A physiological model for simulation of benzene metabolism by rats and mice. Toxicol Appl Pharmacol 99:193-206 (1989).
18. Rickert DE, Baker TS, Bus JS, Barrow CS, Irons RD. Benzene disposition in the rat after exposure by inhalation. Toxicol Appl Pharmacol 49:417-423 (1979).
19. Clewell HJ, Andersen ME, MacNaughton MG. Inhalation pharmacokinetics: inhibitory interactions between n-hexane, methyl-n-butylketone, and 2,5-hexanedione. Toxicologist 4:111 (1984).
20. Kenyon EM, Seeley ME, Janszen D, Medinsky MA. Dose, route and sex-dependent urinary excretion of phenol metabolites in B6C3F1 mice. J Toxicol Environ Health 44:219-233 (1995).
21. NCI. Bioassay of Phenol for Possible Carcinogenicity. Technical Report Series NCI-CG-TR-203. Bethesda, MD:National Cancer Institute, 1980.
22. Gad-El Karim MM, Harper BL, Legator MS. Modifications in the myeloclastogenic effect of benzene in mice with toluene, phenobarbital, 3-methykholanthrene, Aroclor 1254 and SKF-525A. Mutat Res 135:225-243 (1984).
23. Choy WN, MacGregor JT, Shelby MD, Maronpot RR. Induction of micronuclei by benzene in B6C3F1 mice: retro-spective analysis of peripheral blood smears from the NTP carcinogenesis bioassay. Mutat Res. 143:55-59 (1985).
24. Luke CA, Tice RR, Drew RT. The effect of exposure regimen and duration on benzene-induced bone-marrow damage in mice. I. Sex comparison in DBA/2 mice. Mutat Res 203:251-271 (1988).
25. Ciranni R, Barale R, Ghelardini G, Loprieno N. Benzene and the genotoxicity of its metabolites. II: The effect of the route of administration on the micronuclei and bone marrow depression in mouse bone marrow cells. Mutat Res 209:23-28 (1988).
26. Ciranni R, Barale R, Marrazzini A, Loprieno N. Benzene and the genotoxicity of its metabolites. I: Transplacental activity in mouse fetuses and in their dams. Mutat Res 208:61-67 (1988).
27. Gebhardt R. Metabolic zonation of the liver: regulation and implications for liver function. Pharmac Ther 53:275-354 (1992).
28. Morris ME, Pang KS. Competition between two enzymes for substrate removal in liver: modulating effects due to substrate recruitment of hepatocyte activity. J Pharmacokin Biopharm 15:473-496 (1987).
29. Tsutsumi M, Lasker JM, Shimizu M, Rosman AS, Lieber CS. The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology 10:437-446 (1989).
30. Pang KS, Gillette JR. Kinetics of metabolism and elimination in the perfused rat liver preparation: differences between the elimination of preformed acetominophen and acetominophen formed from phenacetin. J Pharmacol Exp Therap 207:178-194 (1978).
31. Pang KS, Terrell JA. Retrograde perfusion to probe the heterogeneous distribution of hepatic drug metabolizing enzymes in rats. J Pharmacol Exp Therap 216:339-346 (1981).
32. 6]benzene. Cancer Res 54:4907-4914 (1994).
33. 6]benzene to rats. Carcinogenesis 14:1921-1925 (1993).
34. McDonald TA, Waidyanatha S, Rapporport SM. Measurement of adducts of benzoquinone with hemoglobin and albumin. Carcinogenesis 14:1927-1932 (1993).
35. Seaton MJ, Schlosser PM, Bond JA, Medinsky MA. Benzene metabolism by human liver microsomes in relation to cytochrome P450 2E1 activity. Carcinogenesis 15:1799-1806 (1994).
36. Chapman DE, Namkung MJ, Juchau MR. Benzene and benzene metabolites as embryotoxic agents: effects on cultured rat embryos. Toxicol Appl Pharmacol 128:129-137 (1994).
37. Kolachana P, Subrahmanyam W, Meyer K, Zhang L, Smith M. Benzene and its phenolic metabolites produce oxidative DNA damage in HL-60 cells in vitro and in the bone marrow in vivo. Cancer Res 53:1023-1026 (1993).
38. Medinsky MA. The application of physiologically-based pharmacokinetic/pharmacodynamic modeling to understanding the mechanism of action of hazardous substances. Toxicol Lett 79:185-191 (1995).
39. Schlosser PM, Kenyon EM, Seaton MJ, Medinsky MA. Determinants of benzene metabolism and disposition. CIIT Activities 15(6):1-10 (1995).